Gideon Valstar

Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre‐ and end‐stage heart failure

Patricia van den Hoogen, Saskia C.A. de Jager, Manon M. H. Huibers et al. · Journal of Cellular and Molecular Medicine · 2019 · 46 citations · Full text

Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community

Aisha Gohar, Rogier F Kievit, Gideon Valstar et al. · European Journal of Preventive Cardiology · 2018 · 22 citations · Full text

Sex-specific microRNAs in women with diabetes and left ventricular diastolic dysfunction or HFpEF associate with microvascular injury

Barend W. Florijn, Gideon Valstar, Jacques M.G.J. Duijs et al. · Scientific Reports · 2020 · 20 citations · Full text

Life-Years Gained by Smoking Cessation After Percutaneous Coronary Intervention

Sanneke P.M. de Boer, Patrick W. Serruys, Gideon Valstar et al. · The American Journal of Cardiology · 2013 · 19 citations

Tobacco Cessation, Tobacco Control, Percutaneous Coronary Intervention +6

Discovery of biomarkers for the presence and progression of left ventricular diastolic dysfunction and HEart faiLure with Preserved ejection Fraction in patients at risk for cardiovascular disease: rationale and design of the HELPFul case-cohort study in a Dutch cardiology outpatient clinic

Gideon Valstar, Sophie H. Bots, Floor Groepenhoff et al. · BMJ Open · 2019 · 18 citations · Full text